Clinical study tests novel topical corneal epithelial stem cell-derived product for treating dry eye disease
Several studies conducted over the last decade have concluded that dry eye disease (DED) affects up to 50% of the U.S. population, creating a liability for the nation's health care system that is estimated to exceed $50 billion annually.